This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Qorvo (QRVO) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
Qorvo's (QRVO) Q2 results are likely to reflect benefits from robust growth in wireless connectivity and base station solutions as well as expanding portfolio of 5G and GaN solutions.
Will Pricing be an Upside for Altria (MO) in Q3 Earnings?
by Zacks Equity Research
Gains from pricing and savings efforts are likely to be reflected on Altria's (MO) Q3 results. However, receding cigarette sales volumes are a concern.
Altria (MO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors Likely to Decide Molson Coors' (TAP) Fate in Q3 Earnings
by Zacks Equity Research
Soft volume, higher marketing expenses and input costs are likely to reflect on Molson Coors' (TAP) third-quarter 2019 results. Also, strong global pricing and innovation may offset headwinds.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $46.75 in the latest trading session, marking a +0.88% move from the prior day.
Things You Must Know Before Boston Beer's (SAM) Q3 Earnings
by Zacks Equity Research
Boston Beer's (SAM) third-quarter 2019 earnings are likely to have been impacted by higher operating costs. However, sturdy depletions and gains from Dogfish Head buyout are tailwinds.
Factors Likely to Decide FEMSA's (FMX) Fate in Q3 Earnings
by Zacks Equity Research
FEMSA (FMX) expects strong top-line results for third-quarter 2019. However, a soft margin trend is expected to get reflected in the bottom-line number.
Philip Morris (PM) Set to Report Q3 Earnings: Where is the Tobacco Giant Headed?
by Christopher Vargas
Philip Morris International (PM) is set to report their third quarter results before the opening bell on Thursday, October 17th.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $42.73, moving +0.38% from the previous trading session.
Top Stock Reports for Cisco, SAP & Gilead
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems (CSCO), SAP (SAP) and Gilead Sciences (GILD).
Will Cigarette Woes Hurt Philip Morris (PM) in Q3 Earnings?
by Zacks Equity Research
Philip Morris' (PM) Q3 performance to gain from pricing and IQOS expansion. However, low cigarette sales volumes are a worry.
The Zacks Analyst Blog Highlights: Kroger, Walmart, Rite Aid, Altria and Phillip Morris
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Kroger, Walmart, Rite Aid, Altria and Phillip Morris
What's Next for Altria (MO) Stock After Kroger (KR), Walmart (WMT), and Other Retailers Abandon E-Cigarette Sales?
by Christopher Vargas
Supermarket giant Kroger (KR) became the latest retailer to discontinue the sale of electronic cigarettes amid regulatory scrutiny.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $42.05, marking a +0.96% move from the previous day.
Philip Morris (PM) Hurt by Low Cigarette Sales, IQOS Expands
by Zacks Equity Research
Philip Morris (PM) is facing lower cigarette shipment volume, which is weighing on revenues. Nevertheless, its IQOS brand is performing well in international markets.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $40.90 in the latest trading session, marking a +1.92% move from the prior day.
Altria Ends Merger Talks, Makes Changes in JUUL & 2019 View
by Zacks Equity Research
Altria (MO) scraps plans to merge with Philip Morris and announces leadership change for JUUL.
Altria (MO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $40.88, marking a +0.17% move from the previous day.
Can Altria Battle Dwindling Cigarette Sales & Vaping Worries?
by Zacks Equity Research
Altria (MO) is reeling under regulatory pressures in the tobacco industry. However, higher pricing is likely to provide support.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $41.31, marking a -0.24% move from the previous day.
Implied Volatility Surging for Altria (MO) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Altria (MO) stock based on the movements in the options market lately.
Philip Morris (PM) Hikes Dividend to Boost Shareholders Value
by Zacks Equity Research
Philip Morris (PM) is consistently boosting shareholders' value via dividend payouts. The company announces dividend hike of 2.6%.
Trump May Ban Flavored E-Cigarettes: Who Wins, Who Loses
by Zacks Equity Research
Vaping is a growing trend among youngsters, but Trump's recent threat to ban flavored e-cigarettes raises questions. Will traditional cigarette get back its lost glory?
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $44.71 in the latest trading session, marking a +1.06% move from the prior day.
Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?
by Benjamin Rains
Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?